InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Breber Sandra, Chief Executive Officer. Director active across 2 companies, notably Augmedix, Inc.. Cumulatively, 4 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €43k. Activity tracked since 28 October 2021. The latest transaction was filed on 2 October 2024 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Breber Sandra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
20,295 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085366:0
6,250 sharesCommon StockSEC:0001213900-24-070867:0
6,250 sharesCommon StockSEC:0001213900-24-044876:0
12,500 shares@ US$4.0050.0% of flowCommon StockSEC:0001213900-21-055926:0
Canonical exit: 26 Jan 2022 (T+90)
4 of 4 declarations
About Breber Sandra
Sandra Breber is the Chief Operating Officer at Augmedix, Inc. She is responsible for managing operations and implementing growth strategies. Her role is essential for ensuring the company's efficiency and profitability.
